Melissa Albert, Infectious Diseases Pharmacy Resident, discusses the recent new literature regarding changes in the clinical breakpoints. Utilizing clinical cases, Dr. Albert demonstrates how to interpret antimicrobial susceptibility reports as well as how to design a patient-centered treatment regimen. Dr. Albert also discusses inducible AmpC-E resistance and how specific breakpoints have been changed for Aminoglycosides.
Stay in touch! Download our new app on the IOS App store: tinyurl.com/id-podcasts
or find us below:
Subscribe to our KZitem Channel: / idpodcasts
Visit us on our webpage: www.idpodcasts.net
Follow us on Facebook: / usfid
Tweet to us: / idpodcasts
Негізгі бет Dropping the MIC; Review of the Updated Breakpoints -- Melissa Albert, PharmD
Пікірлер: 3